FDA seeks input on proposed predecisional process for device trials

06/20/2013 | Clinica (subscription required)

The FDA has released draft guidance governing a new voluntary program that would help clinical trial sponsors assess, prior to submitting an investigational device exemption application, whether the design of their pivotal study would lead to marketing approval. The guidance is up for comment through Sept. 12.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD